Literature DB >> 30979972

Effects of bariatric surgery on telomere length and T-cell aging.

F Jongbloed1,2, R W J Meijers3, J N M IJzermans1, R A Klaassen4, M E T Dollé2, S van den Berg2, M G H Betjes3, R W F de Bruin5, E van der Harst4, N H R Litjens3.   

Abstract

BACKGROUND: Obesity adversely affects health and is associated with subclinical systemic inflammation and features of accelerated aging, including the T-cell immune system. The presence of metabolic syndrome (MetS) may accelerate, while bariatric surgery might reverse these phenomena. To examine the effects of MetS and bariatric surgery on T-cell aging, we measured relative telomere length (RTL) and T-cell differentiation status in obese patients before and after bariatric surgery.
METHODS: WHO II/III classified obese patients scheduled for bariatric surgery were included: 41 without MetS and 67 with MetS. RTL and T-cell differentiation status were measured in circulating CD4+ and CD8+ T cells via flow cytometry. T-cell characteristics were compared between patients with and without MetS prior to and at 3, 6, and 12 months after surgery considering effects of age, cytomegalovirus-serostatus, and weight loss.
RESULTS: Thymic output, represented by numbers of CD31-expressing naive T cells, showed an age-related decline in patients with MetS. MetS significantly enhanced CD8+ T-cell differentiation. Patients with MetS had significant lower CD4+ RTL than patients without MetS. Within the first 6 months after bariatric surgery, RTL increased in CD4+ T cells after which it decreased at month 12. A decline in both thymic output and more differentiated T cells was seen following bariatric surgery, more pronounced in the MetS group and showing an association with percentage of body weight loss.
CONCLUSIONS: In obese patients, MetS results in attrition of RTL and accelerated T-cell differentiation. Bariatric surgery temporarily reverses these effects. These data suggest that MetS is a risk factor for accelerated aging of T cells and that MetS should be a more prominent factor in the decision making for eligibility for bariatric surgery.

Entities:  

Mesh:

Year:  2019        PMID: 30979972     DOI: 10.1038/s41366-019-0351-y

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  6 in total

1.  T and B Cell Composition and Cytokine Producing Capacity Before and After Bariatric Surgery.

Authors:  L H Wijngaarden; A E Taselaar; F Nuijten; E van der Harst; R A Klaassen; T M Kuijper; F Jongbloed; G Ambagtsheer; M Klepper; J N M IJzermans; R W F de Bruin; N H R Litjens
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  Acyl-CoA-binding protein (ACBP): a phylogenetically conserved appetite stimulator.

Authors:  Nikolaos Charmpilas; Christoph Ruckenstuhl; Valentina Sica; Sabrina Büttner; Lukas Habernig; Silvia Dichtinger; Frank Madeo; Nektarios Tavernarakis; José M Bravo-San Pedro; Guido Kroemer
Journal:  Cell Death Dis       Date:  2020-01-06       Impact factor: 8.469

Review 3.  The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19.

Authors:  Daan L de Frel; Douwe E Atsma; Hanno Pijl; Jacob C Seidell; Pieter J M Leenen; Willem A Dik; Elisabeth F C van Rossum
Journal:  Front Nutr       Date:  2020-11-19

4.  The Immunophenotyping Changes of Peripheral CD4+ T Lymphocytes and Inflammatory Markers of Class III Obesity Subjects After Laparoscopic Gastric Sleeve Surgery - A Follow-Up Study.

Authors:  Nasser M Rizk; Amina Fadel; Wasaif AlShammari; Noura Younes; Moataz Bashah
Journal:  J Inflamm Res       Date:  2021-05-05

Review 5.  The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer.

Authors:  Robert C Ross; Yetunde M Akinde; Philip R Schauer; Carel W le Roux; Donal Brennan; Amelia M Jernigan; Marco Bueter; Vance L Albaugh
Journal:  Front Surg       Date:  2022-08-31

Review 6.  Uremia-Associated Immunological Aging and Severity of COVID-19 Infection.

Authors:  Michiel G H Betjes
Journal:  Front Med (Lausanne)       Date:  2021-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.